D. E. Shaw & Co., Inc. Pacira Bio Sciences, Inc. Call Options Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PCRX
# of Institutions
259Shares Held
51MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$170 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$115 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$51 Million0.08% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$45.8 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.13MShares$45.3 Million0.08% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $975M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...